Why the study?
Does adjuvant chemotherapy reduce disease recurrence and improve survival in patients with high-risk soft tissue sarcoma?
Population
Patients with high-risk soft tissue sarcoma (localized, high-grade, large, chemotherapy-sensitive subtypes)
Comparison
Adjuvant chemotherapy vs Treatment without chemotherapy
Design
Review
Authors
Loading...
May support adjuvant chemotherapy in high-risk soft tissue sarcoma; leaves open need for randomized confirmation.
Does adjuvant chemotherapy reduce disease recurrence and improve survival in patients with high-risk soft tissue sarcoma?
Adjuvant chemotherapy with doxorubicin and ifosfamide appears to reduce recurrence and improve survival in selected patients with high-risk soft tissue sarcoma.
Schuetze et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: